Barclays
LFST icon

Barclays’s Lifestance Health LFST Stock Holding History

Barclays’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.26M Sell
603,806
-1,450,608
-71% -$17.1M ﹤0.01% 1842
2026
Q2 		$22M Sell
2,054,414
-711,278
-26% -$5.5M ﹤0.01% 1081
2026
Q1 		$17.6M Sell
2,765,692
-709,803
-20% -$4.94M ﹤0.01% 1160
2025
Q4 		$24.5M Sell
3,475,495
-33,057
-0.9% -$199K 0.01% 1138
2025
Q3 		$19.3M Buy
3,508,552
+1,499,687
+75% +$7.35M ﹤0.01% 1251
2025
Q2 		$10.4M Buy
2,008,865
+581,732
+41% +$3.49M ﹤0.01% 1557
2025
Q1 		$9.5M Buy
1,427,133
+130,445
+10% +$992K ﹤0.01% 1444
2024
Q4 		$9.6M Buy
1,296,688
+27,784
+2% +$199K ﹤0.01% 1609
2024
Q3 		$8.88M Buy
1,268,904
+1,189,594
+1,500% +$7.15M ﹤0.01% 1569
2024
Q2 		$389K Sell
79,310
-32,699
-29% -$197K ﹤0.01% 3197
2024
Q1 		$691K Sell
112,009
-67,454
-38% -$454K ﹤0.01% 3377
2023
Q4 		$1.41M Buy
179,463
+131,902
+277% +$850K ﹤0.01% 3196
2023
Q3 		$327K Buy
47,561
+12,858
+37% +$104K ﹤0.01% 3046
2023
Q2 		$317K Sell
34,703
-1,986
-5% -$16.5K ﹤0.01% 3009
2023
Q1 		$273K Buy
36,689
+17,288
+89% +$95.9K ﹤0.01% 3630
2022
Q4 		$95.8K Buy
19,401
+16,337
+533% +$101K ﹤0.01% 4250
2022
Q3 		$20K Sell
3,064
-13,417
-81% -$93.6K ﹤0.01% 4063
2022
Q2 		$91K Sell
16,481
-3,830
-19% -$29.3K ﹤0.01% 3807
2022
Q1 		$205K Buy
+20,311
New +$178K ﹤0.01% 3417

Other funds holding LFST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Summit Partners
Summit Partners Boston, Massachusetts $491M AUM 11.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Barclays's LFST Position: Q3 2026 in Review

Barclays reduced its Lifestance Health (LFST) stake by 71% in Q3 2026, selling an estimated $17.1M and leaving 603,806 shares worth $7.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

Barclays first reported a position in LFST in Q1 2022 and has held it in 19 quarters since. The position peaked at $24.5M in Q4 2025. 252 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Barclays held 603,806 shares of Lifestance Health worth $7.26M as of Q3 2026.
  • Barclays sold 1,450,608 Lifestance Health shares in Q3 2026, an estimated $17.1M.
  • Lifestance Health made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1842 holding.
  • Barclays first reported a position in Lifestance Health in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Lifestance Health position peaked at $24.5M in Q4 2025.
  • 252 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.